- Report
- October 2024
- 190 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- April 2025
- 88 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- March 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- October 2024
- 250 Pages
Global
From €4691EUR$4,949USD£3,919GBP
- Report
- October 2021
- 248 Pages
Global
From €4692EUR$4,950USD£3,920GBP
- Report
- May 2022
- 100 Pages
Global
From €5640EUR$5,950USD£4,711GBP
- Report
- January 2020
- 327 Pages
Global
From €3791EUR$4,000USD£3,167GBP
- Report
- March 2024
- 149 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Report
- December 2020
- 280 Pages
Global
From €4218EUR$4,450USD£3,524GBP
- Report
- January 2022
- 60 Pages
Global
From €3744EUR$3,950USD£3,128GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1185EUR$1,250USD£990GBP
- Report
- February 2024
- 117 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- May 2022
- 43 Pages
Global
From €1896EUR$2,000USD£1,584GBP
- Report
- August 2024
- 320 Pages
Global
From €2516EUR$2,655USD£2,102GBP

The Male Infertility Drug market is a subset of the Sexual and Reproductive Health Drugs market. It includes drugs used to treat male infertility, such as those used to increase sperm count, motility, and morphology. These drugs are typically prescribed to men who have difficulty conceiving due to low sperm count or poor sperm quality. They may also be used to treat conditions such as varicocele, which can cause infertility.
In addition to drugs, the Male Infertility Drug market also includes other treatments such as assisted reproductive technologies (ARTs) and lifestyle modifications. ARTs include in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Lifestyle modifications may include dietary changes, exercise, and stress management.
Some companies in the Male Infertility Drug market include Bayer AG, Merck & Co., Inc., Pfizer Inc., and Teva Pharmaceutical Industries Ltd. Show Less Read more